ITEOS THERAPEUTICS INC (ITOS) Stock Analyst Earnings Estimates
NASDAQ:ITOS - Nasdaq - US46565G1040 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 344.8M | 267.6M -22.39% | 12.595M -95.29% | 46.75M 271.18% | 6.828M -85.39% | 15.138M 121.70% | 117.94M 679.10% | 91.648M -22.29% | 166.74M 81.94% | 256.94M 54.10% | 525.94M 104.69% | 541.4M 2.94% | |
| EBITDA YoY % growth | 245.5M 649.22% | 127.1M -48.23% | -150.203M -218.18% | -163.2M -8.65% | -178.5M -9.38% | -202.98M -13.71% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 244.9M 641.81% | 126.3M -48.43% | -151.101M -219.64% | -167.772M -11.03% | -219.46M -30.81% | -245.455M -11.84% | -182.308M 25.73% | -172.676M 5.28% | -85.285M 50.61% | 5.486M 106.43% | 180.55M 3,191.10% | 180.91M 0.20% | |
| Operating Margin | 71.03% | 47.20% | -1,199.69% | -358.87% | -3,214.12% | -1,621.45% | -154.58% | -188.41% | -51.15% | 2.14% | 34.33% | 33.42% | |
| EPS YoY % growth | 5.61 334.29% | N/A -50.69% | -3.15 -213.87% | -3.41 -8.35% | -4.11 -20.44% | -4.29 -4.47% | -3.28 23.59% | -2.45 25.29% | -1.06 56.73% | 0.04 104.16% | 2.72 6,066.28% | 2.71 -0.37% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.09 -27.68% | -1.08 -0.67% | -1.12 -524.47% | -1.07 -1.81% | -0.96 11.28% | -1.32 -22.63% | -1.34 -18.97% | -1.35 -26.34% | -1.36 -41.42% | -2.03 -53.90% | -1.76 -31.50% | -1.57 -16.47% |
| Revenue Q2Q % growth | -100.00% | 807.33K | N/A | N/A | N/A | N/A | N/A | N/A | 4.709M | |||
| EBITDA Q2Q % growth | -51M -29.94% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -55.453M -38.13% | -66.137M -40.03% | -67.269M -374.86% | -67.33M -37.98% | -68.289M -23.15% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.05 -16.67% | -0.91 | -0.14 | -15.79% |
| Q2 2024 Q2Q % growth | -0.18 81.25% | -1.06 | 0.88 | 82.99% |
| Q1 2024 Q2Q % growth | -1.07 -143.18% | -1.28 | 0.21 | 16.49% |
| Q4 2023 Q2Q % growth | -0.85 -349.75% | -1.05 | 0.20 | 19.34% |
| Q3 2023 Q2Q % growth | -0.90 -3,100.00% | -1.23 | 0.33 | 26.68% |
| Q2 2023 Q2Q % growth | -0.96 -740.00% | -1.05 | 0.09 | 8.62% |
| Q1 2023 Q2Q % growth | -0.44 -124.18% | -1.01 | 0.57 | 56.62% |
| Q4 2022 Q2Q % growth | -93.04% | 0.34 | % | |
| Q3 2022 Q2Q % growth | 0.03 -98.39% | 0.10 | -0.07 | -69.83% |
| Q2 2022 Q2Q % growth | 0.15 120.00% | 1.23 | -1.08 | -87.77% |
| Q1 2022 Q2Q % growth | 1.82 566.67% | 0.81 | 1.01 | 124.44% |
| Q4 2021 Q2Q % growth | 4.89 1,237.21% | 1.30 | 3.59 | 275.13% |
| Q3 2021 Q2Q % growth | 1.86 487.50% | 5.05 | -3.19 | -63.18% |
| Q2 2021 Q2Q % growth | -0.75 97.46% | -0.42 | -0.33 | -77.61% |
| Q1 2021 Q2Q % growth | -0.39 | -0.49 | 0.10 | 20.01% |
| Q4 2020 Q2Q % growth | -0.43 | -0.43 | 0.00 | 0.22% |
| Q3 2020 Q2Q % growth | -0.48 | -0.37 | -0.11 | -29.28% |
| Q2 2020 Q2Q % growth | -29.49 | -0.48 | -29.01 | -6,084.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 17M | -17M | -100.00% | |
| Q2 2024 Q2Q % growth | 35M | 1.02M | 33.98M | 3,331.37% |
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | % | ||
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | 12.595M -91.74% | 8.199M | 4.396M | 53.62% |
| Q4 2022 Q2Q % growth | 53.9M -77.59% | 41.979M | 11.921M | 28.40% |
| Q3 2022 Q2Q % growth | 19.5M -81.30% | 42.889M | -23.389M | -54.53% |
| Q2 2022 Q2Q % growth | 41.7M | 87.269M | -45.569M | -52.22% |
| Q1 2022 Q2Q % growth | 152.5M | 64.566M | 87.934M | 136.19% |
| Q4 2021 Q2Q % growth | 240.5M | 87.168M | 153.332M | 175.90% |
| Q3 2021 Q2Q % growth | 104.3M | 164.35M | -60.05M | -36.54% |
| Q2 2021 Q2Q % growth | 3.984M | -3.984M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 13.73% | 13.85% | 0% | 15.9% |
| Revenue | N/A | N/A | 0% | 0% |